“Hard Brexit” and its impact on the medi­cal device industry

BREXIT has effects across indus­tries, affec­ting medi­cal device manu­fac­tu­r­ers, their dis­tri­bu­ti­on pos­si­bi­li­ties in Gre­at Bri­tain and the impor­ta­ti­on of medi­cal devices into the EU 27. The ans­wer to the ques­ti­on of what effects it will have on the medi­cal devices indus­try and to what degree will depend to a lar­ge ext­ent on whe­ther BREXIT will be “hard” or “soft”.

For the case of a “hard BREXIT”, the Bri­tish Medi­ci­nes and Health­ca­re pro­ducts Regu­la­to­ry Agen­cy (MHRA) has published new gui­de­lines for medi­cal devices that are to be mar­ke­ted in Gre­at Bri­tain (and Nor­t­hern Ire­land and the EU) as of 1 Janu­ary 2021. After a “hard BREXIT” wit­hout agree­ment, the United King­dom will be con­side­red as a third coun­try. This means that manu­fac­tu­r­ers of medi­cal devices based in the Gre­at Bri­tain will need to retain a Euro­pean Aut­ho­ri­sed Repre­sen­ta­ti­ve domic­i­led in the EU 27. This com­mis­sio­ning pro­cess can be time-consuming. In addi­ti­on, as of 1 Janu­ary 2021, the Noti­fied Bodies (still) based in Gre­at Bri­tain will no be lon­ger allo­wed to issue CE mar­kings. As of the date the MDR enters into force on 26 May 2021, co-operation with an MDR-accredited Noti­fied Body based in the EU 27 will be requi­red. Impor­ta­ti­on of pro­ducts into the EU 27 will fol­low the rules of impor­ta­ti­on from a third coun­try. Importers will be sub­ject to the obli­ga­ti­ons of importers under the MDR, which go bey­ond the obli­ga­ti­ons of mere distributors.

Con­ver­se­ly, howe­ver, this will also app­ly to the access of Bri­tish devices to the Euro­pean market.

Manu­fac­tu­r­ers based out­side the United King­dom must desi­gna­te a UK Respon­si­ble Per­son in con­nec­tion with the new regis­tra­ti­on requi­re­ments. Coope­ra­ti­on with a Bri­tish part­ner will thus be essen­ti­al for the mar­ke­ta­bi­li­ty of Euro­pean medi­cal devices in Gre­at Bri­tain in the future. A UK Respon­si­ble Per­son will need to have been appoin­ted by 1 Janu­ary 2021. A tran­si­tio­nal peri­od exists for regis­tra­ti­on at the MHRA that is ali­gned with the plan­ned time frame for regis­tra­ti­on of devices in the indi­vi­du­al risk clas­ses. The pri­ma­ry respon­si­bi­li­ty of UK Respon­si­ble Per­sons will con­sist pre­cis­e­ly in this regis­tra­ti­on of non-UK manu­fac­tu­r­ers and their devices. Fur­ther respon­si­bi­li­ties descri­bed in the gui­de­lines essen­ti­al­ly cor­re­spond to tho­se of MDR and IVDR Aut­ho­ri­sed Repre­sen­ta­ti­ves. Examp­les of such respon­si­bi­li­ties include ensu­ring the avai­la­bi­li­ty of decla­ra­ti­ons of con­for­mi­ty and tech­ni­cal docu­men­ta­ti­on, and the kee­ping of copies of the rele­vant docu­ments and cer­ti­fi­ca­tes. After the tran­si­tio­nal peri­od for the vali­di­ty of the CE mar­king in Gre­at Bri­tain (end: 30 June 2023), a UK Con­for­mi­ty Asses­sed (UKCA) mar­king will also be requi­red for devices. Howe­ver, if a device is in com­pli­ance with both EU legis­la­ti­on and the new Bri­tish legis­la­ti­on, it will likely also be accep­ta­ble after 1 July 2023 for a device to be both CE and UKCA mark­ed. How such dou­ble mar­kings will take place in prac­ti­ce, in par­ti­cu­lar what infor­ma­ti­on will be affi­xed to the UKCA mar­king, remains to be work­ed out.

The spe­cial sta­tus for Nor­t­hern Ire­land nego­tia­ted thus far should be empha­sis­ed: due to the open bor­der with the Repu­blic of Ire­land, it has been plan­ned to date for EU regu­la­ti­ons to con­ti­nue to app­ly the­re in the future. A spe­cial arran­ge­ment has been made and a sepa­ra­te UK(NI) mar­king deve­lo­ped, who­se joint use along with the CE mar­king has been envi­sa­ged. Devices with the UK(NI) mar­king are only to be on the mar­ket in the UK and Nor­t­hern Ire­land, not in the rest of the EU. In con­trast, the CE mar­king will be reco­g­nis­ed both in Nor­t­hern Ire­land and the rest of the EU, but not in Gre­at Bri­tain after 30 June 2023. It is impos­si­ble to fore­see whe­ther this spe­cial arran­ge­ment will actual­ly come into force by way of the “Inter­nal Mar­ket Bill”, which was intro­du­ced into Par­lia­ment on 9 Sep­tem­ber 2020. The EU is curr­ent­ly pre­pa­ring legal pro­cee­dings against Gre­at Bri­tain becau­se it holds that the Inter­nal Mar­ket Bill vio­la­tes the joint­ly nego­tia­ted exit agreement.

Ulti­m­ate­ly, after the dead­lo­cked BREXIT nego­tia­ti­ons, the ques­ti­on of whe­ther BREXIT will be hard or soft and the con­se­quen­ces the­reof remains open. It remains to be seen whe­ther the recent ulti­ma­tum given by Boris John­son for an exe­cu­ta­ble trade agree­ment on 15 Octo­ber 2020 will be enough to avert a hard BREXIT.

The text reflects the sta­te of the deba­te as of 11 Octo­ber 2020. We keep you updated.


Stay up-to-date

We use your email address exclusively for sending our newsletter. You have the right to revoke your consent at any time with effect for the future. For further information, please refer to our privacy policy.